Itama Ranoraya
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. The company offers in vitro diagnostics products comprising rapid test and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; cardiovascular, urology, and surgical … Read more
Itama Ranoraya (IRRA) - Total Liabilities
Latest total liabilities as of September 2025: Rp2.16 Trillion IDR
Based on the latest financial reports, Itama Ranoraya (IRRA) has total liabilities worth Rp2.16 Trillion IDR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Itama Ranoraya - Total Liabilities Trend (2016–2024)
This chart illustrates how Itama Ranoraya's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Itama Ranoraya Competitors by Total Liabilities
The table below lists competitors of Itama Ranoraya ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Electricite et Eaux de Madagascar SA
PA:EEM
|
France | €6.79 Million |
|
RGT Bhd
KLSE:9954
|
Malaysia | RM96.65 Million |
|
Softcen Co. Ltd
KQ:032680
|
Korea | ₩29.56 Billion |
|
Jayjun Co Ltd
KO:025620
|
Korea | ₩10.80 Billion |
|
Urgent.ly Inc. Common Stock
NASDAQ:ULY
|
USA | $87.95 Million |
Liability Composition Analysis (2016–2024)
This chart breaks down Itama Ranoraya's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 3.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Itama Ranoraya's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Itama Ranoraya (2016–2024)
The table below shows the annual total liabilities of Itama Ranoraya from 2016 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | Rp1.15 Trillion | +91.21% |
| 2023-12-31 | Rp599.69 Billion | +139.99% |
| 2022-12-31 | Rp249.88 Billion | -10.75% |
| 2021-12-31 | Rp279.99 Billion | -4.42% |
| 2020-12-31 | Rp292.94 Billion | +224.54% |
| 2019-12-31 | Rp90.26 Billion | +29.66% |
| 2018-12-31 | Rp69.62 Billion | -16.45% |
| 2017-12-31 | Rp83.32 Billion | +407.44% |
| 2016-12-31 | Rp16.42 Billion | -- |